ArticleBritish journal of pharmacology1992
Characterization of potassium currents modulated by BRL 38227 in rat portal vein.
Article in British journal of pharmacology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 61 citations in OpenAlex.
- Heme oxygenase-2 products activate IKCa: role of CO and iron in guinea pig portal vein smooth muscle cells.Journal of muscle research and cell motility · 2004Article
- Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.British journal of pharmacology · 1999Article
- Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.The Journal of physiology · 1999Article
- Multiple types of ion channels in cavernous smooth muscle.World journal of urology · 1997Review
- Pharmacological characterization of the inwardly-rectifying current in the smooth muscle cells of the rat bladder.British journal of pharmacology · 1996Article
- Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein.British journal of pharmacology · 1996Article
- Activation of potassium currents by inhibitors of calcium-activated chloride conductance in rabbit portal vein smooth muscle cells.British journal of pharmacology · 1996Article
- Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells.British journal of pharmacology · 1996Article
- Investigation of the effects of 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) on membrane currents in rat portal vein.British journal of pharmacology · 1996Article
- Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.British journal of pharmacology · 1995Article
- Effects of BRL55834 in rat portal vein and bovine trachea: evidence for the induction of a glibenclamide-resistant, ATP-sensitive potassium current.British journal of pharmacology · 1995Article
- Pharmacology of the potassium channel openers.Cardiovascular drugs and therapy · 1995Review
- Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery.British journal of pharmacology · 1995Article
- Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle.British journal of pharmacology · 1994Article
- Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.Naunyn-Schmiedeberg's archives of pharmacology · 1994Article
- Properties of the ATP-sensitive K+ current activated by levcromakalim in isolated pulmonary arterial myocytes.The Journal of membrane biology · 1994Article
- Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery.Naunyn-Schmiedeberg's archives of pharmacology · 1994Article
- ATP-sensitive K+ channel opener acts as a potent Cl- channel inhibitor in vascular smooth muscle cells.The Journal of membrane biology · 1994Article
- Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier.British journal of pharmacology · 1993Article
- Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier.British journal of pharmacology · 1993Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1. Smooth muscle cells of the rat portal vein were dispersed by enzymatic treatment and recordings of whole-cell membrane potassium currents were made by the voltage-clamp technique. In isolated cells by use of combined voltage- and current-clamp the effect of BRL 38227 on membrane potential and ionic currents was also studied. 2. BRL 38227 (0.1 to 10 microM) induced a non-inactivating potassium current (IKCO) which developed slowly (900 s to 300 s, respectively) to its full size. These effects of BRL 38227 were reversible. 3. In addition to its K-channel opening properties, BRL 38227 (1 to 10 microM) inhibited the amplitude and changed the activation and inactivation characteristics of a slowly-inactivating, calcium influx-independent, outward potassium current (I(TO)). 4. Application of stationary fluctuation analysis to IKCO, showed a mean single channel current of 0.65 pA at -10 mV under a quasi-physiological potassium gradient. 5. In a combined voltage-clamp/current-clamp configuration, BRL 38227 (1 microM) induced a mean hyperpolarization of 22 mV. 6. The induction of IKCO by BRL 38227 and the associated hyperpolarization were suppressed by glibenclamide (1 to 10 microM) in a concentration-dependent manner. Glibenclamide (1 microM) had no effect on the inhibition of I(TO) by BRL 38227 (1 microM).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.